Keywords: biogen, idec, 4th-qtr, profit, up, 109m, usa-based
Biogen Idec's 4th-qtr profit up 95% to $109M
Article | 26 February 2007
USA-based biotechnology firm Biogen Idec says that, for the fourth quarter 2006, its income was $108.6 million, or $0.32 per share, up 95.3% on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
